Kristin Patrick's most recent trade in Niagen Bioscience Inc. was a trade of 23,000 Common Stock done at an average price of $3.6 . Disclosure was reported to the exchange on Aug. 23, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Niagen Bioscience Inc. | Kristin Patrick | Director | Sale of securities on an exchange or to another person at price $ 3.57 per share. | 23 Aug 2024 | 23,000 | 0 (0%) | 0% | 3.6 | 82,110 | Common Stock |
| Niagen Bioscience Inc. | Kristin Patrick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Niagen Bioscience Inc. | Kristin Patrick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.67 per share. | 23 Aug 2024 | 20,000 | 23,000 (0%) | 0% | 1.7 | 33,400 | Common Stock |
| Niagen Bioscience Inc. | Kristin Patrick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 23 Aug 2024 | 3,000 | 3,000 (0%) | 0% | 1.6 | 4,920 | Common Stock |
| Niagen Bioscience Inc. | Kristin Patrick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 3,000 | 17,000 | - | - | Stock Option (right to buy) | |
| Niagen Bioscience Inc. | Kristin Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Niagen Bioscience Inc. | Kristin Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Super League Enterprise Inc | Kristin Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 60,000 | 114,273 (1%) | 0% | - | Common Stock | |
| Niagen Bioscience Inc. | Kristin Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Niagen Bioscience Inc. | Kristin Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Super League Enterprise Inc | Kristin Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 12,474 | 54,273 (0%) | 0% | 0 | Common Stock | |
| Super League Enterprise Inc | Kristin Patrick | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 36,344 | 41,799 (0%) | 0% | - | Common Stock |